Lamprey immunity

Researchers at the University of Tokyo showed that jawless sea lampreys use a specific immune response mechanism involving "copy choice" that creates variable lymphocyte receptors (VLRs).1 This mechanism differs from the system in most vertebrates, which involves somatic recombination producing immunoglobulin receptors. "This species has such an evolutionarily interesting position," says Faculty of 1000 member Joachim Kurtz at the Institute for Advanced Study in Berlin. "It's no

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Researchers at the University of Tokyo showed that jawless sea lampreys use a specific immune response mechanism involving "copy choice" that creates variable lymphocyte receptors (VLRs).1 This mechanism differs from the system in most vertebrates, which involves somatic recombination producing immunoglobulin receptors.

"This species has such an evolutionarily interesting position," says Faculty of 1000 member Joachim Kurtz at the Institute for Advanced Study in Berlin. "It's not an invertebrate but more primitive than a jawed fish, it's somewhere in between."

In this mechanism that generates diverse immunological receptors, only a portion of the germ line is copied into the rearranged VLR, yielding one antigen response gene per lymphocyte. The more common vertebrate mechanism involves a complex recombination and deletion process, whereas a third mechanism, found in invertebrates, involves alternative splicing of the genome.

"What fascinates me is there seems to be evolutionary constraint on the [immune] system that leads to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies